NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in KBR, Inc. ("KBR, Inc." or the "Company") (NYSE: KBR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KBR, Inc. investors who were adversely affected by alleged securities fraud between May 6, 2025 and June 19, 2025.

image for news Class Action Filed Against KBR, Inc. (KBR) Seeking Recovery for Investors - Contact Levi & Korsinsky

Kupcho surges to the top of the season-long standings showcasing exceptional resilience and clutch decision-making NAPLES, Fla. , Nov. 18, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, and the LPGA Tour today announced Jennifer Kupcho as the winner of the 2025 Aon Risk Reward Challenge, securing the title in dramatic fashion during the final event of the regular season.

image for news Jennifer Kupcho Clinches $1 Million Aon Risk Reward Challenge Title in Final-Event Comeback

Waystar to Participate in Upcoming Investor Conferences — Neutral

WAY   PRNewsWire — November 18, 2025

LEHI, Utah and LOUISVILLE, Ky. , Nov. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins and Chief Financial Officer Steve Oreskovich will participate in three upcoming investor conferences: 8th Annual Evercore ISI HealthCONx Conference: Mr.

image for news Waystar to Participate in Upcoming Investor Conferences

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inspire Medical Systems, Inc. investors who were adversely affected by alleged securities fraud between August 6, 2024 and August 4, 2025.

image for news Levi & Korsinsky Notifies Shareholders of Inspire Medical Systems, Inc.(INSP) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd.

image for news Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - TLX

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MoonLake investors who were adversely affected by alleged securities fraud between March 10, 2024 and September 29, 2025.

image for news MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter International, Inc. investors who were adversely affected by alleged securities fraud between February 23, 2022 and July 30, 2025.

image for news Levi & Korsinsky Notifies Baxter International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BAX

Warren Buffett's Berkshire Hathaway (NYSE:BRK-B) just made a rather surprising bet on shares of AI titan Alphabet (NASDAQ:GOOG) last quarter.

image for news Warren Buffett's Berkshire Just Bought Alphabet Stock—Why Investors Would Be Wise to Follow

Vancouver, Canada, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced positive top-line results from the first cohort of its Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate for the treatment of Alcohol Use Disorder (AUD).

image for news Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Team's Q3 Earnings Fall Y/Y Despite Strong Revenue Gains — Positive

TISI   Zacks Investment Research — November 18, 2025

TISI shares decline after Q3 earnings results, but rising revenues, stronger margins and improving segment performance highlight ongoing progress in its transformation plan.

image for news Team's Q3 Earnings Fall Y/Y Despite Strong Revenue Gains

Medtronic (MDT) Q2 Earnings and Revenues Top Estimates — Positive

MDT   Zacks Investment Research — November 18, 2025

Medtronic (MDT) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.26 per share a year ago.

image for news Medtronic (MDT) Q2 Earnings and Revenues Top Estimates

5 Things to Know Before the Stock Market Opens — Negative

HD   Investopedia — November 18, 2025

Stock futures are lower Tuesday morning after major indexes fell sharply to open the week; Home Depot reported lower quarterly profits than analysts had expected; Apple's new iPhone 17 gave the smartphone maker its best month of market share in China in three years; Nvidia stock is moving lower again as investors prepare for the chipmaker's results; and buy now, pay later firm Klarna posted its first earnings report since going public in September. Here's what investors need to know today.

image for news 5 Things to Know Before the Stock Market Opens

OCALA, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today provided a business update and reported its financial results for the third quarter 2025.

image for news AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program

Nvidia: $4 Trillion+ Data Center Opportunity — Positive

NVDA   Seeking Alpha — November 18, 2025

Nvidia management expects to benefit from the huge $3-4 trillion in AI infrastructure spending over the next five years. Nvidia's competitive advantage remains solid as it continues to lead in performance and stays ahead of competitors. We believe that Nvidia's software revenue opportunity could also grow as GPU shipments expand.

image for news Nvidia: $4 Trillion+ Data Center Opportunity

TeraWulf: Rich AI Prospects In 2026/2027 - Dip Buying Opportunity — Positive

WULF   Seeking Alpha — November 18, 2025

WULF finally nears my Buy Zone after the recent meltdown, as it also reports robust AI related opportunities and higher multi-year contracted backlog. The company is more than well positioned to monetize their ambitious "target of 250–500 MW critical IT load of new HPC lease signings annually," thanks to the growing HPC capacity. WULF's projected NOI margin of over ~70% is extremely impressive as well, compared to other data center REITs, with it implying its robust top/ bottom-line growth prospects.

image for news TeraWulf: Rich AI Prospects In 2026/2027 - Dip Buying Opportunity

How Does Bank of America Plan to Achieve ROTCE Target of 16-18%? — Positive

BAC   Zacks Investment Research — November 18, 2025

BAC targets a 16-18% ROTCE with plans centered on revenue growth, tech-driven efficiency and stronger client engagement.

image for news How Does Bank of America Plan to Achieve ROTCE Target of 16-18%?

Is JPMorgan's High-Single-Digit Revenue Growth Cycle Built to Last? — Positive

JPM   Zacks Investment Research — November 18, 2025

JPMorgan posts broad-based revenue gains as rising trading, IB activity and wealth strength offset emerging NII pressure from rate cuts.

image for news Is JPMorgan's High-Single-Digit Revenue Growth Cycle Built to Last?

NEW YORK--(BUSINESS WIRE)--Regulatory News: Klarna, the global digital bank and flexible payments provider, reported record results in its first quarter as a public company, surpassing analyst expectations. The company expects to exceed $1 billion in revenue in Q4 2025, its first billion-dollar quarter. Sebastian Siemiatkowski, CEO & Co-Founder, said: “Q3 was our strongest quarter ever — proof that our AI-driven model is working at scale, with U.S. revenue up 51% and GMV up 43%. The Klarn.

image for news Klarna Delivers Record-breaking Q3 as AI-Powered Digital Bank: $903 Million in Revenue and 4 Million Card Sign-ups in 4 Months

NEW YORK--(BUSINESS WIRE)--Regulatory News: Klarna, the global digital bank and flexible payments provider, reported record results in its first quarter as a public company, surpassing analyst expectations. The company expects to exceed $1 billion in revenue in Q4 2025, its first billion-dollar quarter. Sebastian Siemiatkowski, CEO & Co-Founder, said: “Q3 was our strongest quarter ever — proof that our AI-driven model is working at scale, with U.S. revenue up 51% and GMV up 43%. The Klarna.

image for news Klarna Delivers Record-breaking Q3 as AI-Powered Digital Bank: $903 Million in Revenue and 4 Million Card Sign-ups in 4 Months

New Fortress Energy Signs Forbearance Agreement — Neutral

NFE   Business Wire — November 18, 2025

NEW YORK--(BUSINESS WIRE)--New Fortress Energy Inc. (NASDAQ: NFE) (“NFE” or the “Company”) today announced that it has signed a forbearance agreement with representatives of the holders of its new senior secured notes due 2029. Under this agreement, the due date for interest payments scheduled for November 17, 2025 has been effectively extended to December 15, 2025. During the forbearance period, NFE expects to continue to work constructively with the company's stakeholders. About New Fortress.

image for news New Fortress Energy Signs Forbearance Agreement